Canopy Growth Corp vs Snap Inc — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Snap Inc trades at $4.68 (market cap $7.87B). The key difference: Snap Inc is far larger — about 19.8× Canopy Growth Corp's market cap. Which is the better fit depends on your goals.
| CGC | SNAP | |
|---|---|---|
Market Cap | $398.46M | $7.87B |
Sector | Health | Media |
52-Week High | $1.92 | $10.35 |
52-Week Low | $0.86 | $3.93 |
Enterprise Value | $337.90M | $9.25B |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Snap Inc. (SNAP) trades at $4.665, down 0.32% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $5.93B in 2025, with a net loss of $460.49M, though losses have narrowed year-over-year. Recent news highlights the launch of high-priced AR glasses, which has drawn investor skepticism and contributed to stock volatility.
The outlook remains cautious; while cost-cutting and revenue growth offer potential, persistent losses, high debt, and competitive pressures pose significant risks. Analyst consensus is mixed with a $6.82 price target, suggesting moderate upside if execution improves, but the stock faces headwinds from weak profitability and market sentiment.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →